Advertisement

Simplifying HIV Treatment in the Presence of Drug Resistance; Preventing from the Start - Episode 5

Importance of Starting HIV Treatment Early

Published on: 
, , ,

The panel discusses the importance of starting HIV treatment early after diagnosis and offers advice to clinical providers.

BIC = bictegravir

DRV = darunavir

DTG = dolutegravir

F/TAF = FTC/TAF = Emtricitabine/Tenofovir alafenamide

F/TDF = FTC/TDF = Emtricitabine/Tenofovir disoproxil fumarate

B/F/TAF = BIC/FTC/TAF = Bictegravir/Emtricitabine/Tenofovir alafenamide (single tablet regimen)

DTG/ABC/3TC = Dolutegravir/Abacavir/Lamivudine (single tablet regimen)

DTG + F/TAF = DTG + FTC/TAF = Dolutegravir + Emtricitabine/Tenofovir alafenamide (multi-tablet regimen)

D/C/F/TAF = DRV/COBI/FTC/TAF = Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (single tablet regimen)

DTG/3TC = Dolutegravir/Lamivudine (single tablet regimen)

CAB = Cabotegravir

CAB + RPV = Cabotegravir + Rilpivirine

Video content above is prompted by the following question:

1. Can you emphasize the importance of starting HIV treatment early after diagnosis?

  • How do you go about educating your patient on initiating treatment and set them up for long term success?
    • Do you start treatment the same day as the patient gets diagnosed? (Preferred regiments for rapid start?)
    • Undetectable=untransmissible
  • How do you identify barriers that may affect your patients’ treatment goals?
Advertisement
Advertisement